Sadahisa Ogasawara
0000-0002-6540-9064
Publication & Citation Trends
Publications
335 total
Exploration of HER2 expression in advanced hepatocellular carcinoma using tumor biopsy samples.
Cited by 0
Semantic Scholar
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naive Advanced Hepatocellular Carcinoma: Long-Term Follow-Up of Open-Label, Phase 2 KEYNOTE-224 Study.
Cited by 0
Semantic Scholar
A multicenter phase II study on atezolizumab plus bevacizumab combination therapy in patients with unresectable hepatocellular carcinoma and Child–Pugh classification B cirrhosis: CHALLENGE trial
Cited by 0
Semantic Scholar
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post‐Progression Outcomes: A Multicenter Real‐World Study in Advanced Hepatocellular Carcinoma
Cited by 0
Semantic Scholar
Cholestasis-reducing effects of bezafibrate on survivors of biliary atresia with native livers: A prospective phase II trial
Cited by 0
Semantic Scholar
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.
Cited by 0
Semantic Scholar
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma
Cited by 0
Semantic Scholar
Real-world prospective comparison of sorafenib and lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: A multicenter study in Japan (KSCC HAMRET).
Cited by 0
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(235)
Liver Disease Diagnosis and Treatment
(87)
Cancer Immunotherapy and Biomarkers
(57)
Pancreatic and Hepatic Oncology Research
(51)
Cancer Mechanisms and Therapy
(44)
Affiliations
Obayashi (Japan)
Suzuki (Japan)
Chiba University
Pediatric Nephrology of Alabama
Chiba University Hospital